# Corus Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corus-pharma

- Industry: Pharmaceuticals
- Headquarters: Seattle, US
- Total disclosed funding: $119M
- Latest round: Series C (Apr 1, 2004)
- Investors on record: 13

## About

Founded in 2001 and based in Washington, US, Corus Pharma, Inc. is a biopharmaceutical company that develops specialty drugs for treating respiratory diseases.

## Funding rounds

- Series C, Apr 1, 2004, $60M — MPM BioImpact, Hambrecht & Quist, SunAmerica Ventures, Bear Stearns Health Innoventures
- Series B, Mar 10, 2003, $40M — Burrill & Company, Integra Ventures, OrbiMed Advisors, RBC Capital Markets, Cascade Investment, Novo Holdings, Anthem Venture Partners, Washington Research Group, Lumira Ventures
- Series A, Jun 1, 2001, $19M — Burrill & Company, OrbiMed Advisors, Cascade Investment

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B
- Cascade Investment — Series A, Series B
- Integra Ventures (https://capitalatlas.ai/funds/integra-ventures) — Series B
- RBC Capital Markets (https://capitalatlas.ai/funds/rbc-capital-markets) — Series B
- Novo Holdings — Series B
- Anthem Venture Partners (https://capitalatlas.ai/funds/anthem-venture-partners) — Series B
- Washington Research Group — Series B
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series B
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series C
- Hambrecht & Quist (https://capitalatlas.ai/funds/hambrecht-quist) — Series C
- SunAmerica Ventures — Series C
- Bear Stearns Health Innoventures (https://capitalatlas.ai/funds/bear-stearns-health-innoventures) — Series C